ResearchLong-Term Mortality among Hospitalized Adults with Sepsis in Uganda: A Prospective Cohort Study
Mar 17, 2026Journal ArticleEffectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024.Written by 1 Roon author & 60 others Via Clinical Infectious Diseases
Mar 17, 2026Journal ArticleMultimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus.+1Written by 3 Roon authors & 43 others Via Clinical Infectious Diseases
ResearchIncidence Rates of RSV-Associated Hospitalizations Among Adults in Middle Tennessee, United States, October 2022 Through September 2023
ResearchEffectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes — IVY Network, 26 Hospitals, September 1, 2024–April 30, 2025
ResearchPrecision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae
Aug 1, 2025Journal ArticleBenefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study.+2Written by 4 Roon authors & 53 others Via Clinical Infectious Diseases
ResearchPatient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination
ResearchComparison of Immunization Information Systems, Electronic Medical Records, and Self-Report to Ascertain RSV Vaccination Status Among US Adults Aged ≥60 Years, 2023-2024
ResearchVaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024
ResearchRSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons